How big is the Plasmid DNA Contract Manufacturing Market?

The Plasmid DNA Contract Manufacturing Market size is expected to reach USD 5.52 billion in 2024 and grow at a CAGR of 14.5% to reach USD 12.44 billion by 2029. Read More

What is the current Plasmid DNA Contract Manufacturing Market size?

In 2024, the Plasmid DNA Contract Manufacturing Market size is expected to reach USD 5.52 billion. Read More

Who are the key players in Plasmid DNA Contract Manufacturing Market?

Lonza, PlasmidFactory GmbH & Co. KG., BioCina, Charles River Laboratories and Catalent Inc. are the major companies operating in the Plasmid DNA Contract Manufacturing Market. Read More

Which is the fastest growing region in Plasmid DNA Contract Manufacturing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Plasmid DNA Contract Manufacturing Market?

In 2024, the North America accounts for the largest market share in Plasmid DNA Contract Manufacturing Market. Read More

What years does this Plasmid DNA Contract Manufacturing Market cover, and what was the market size in 2023?

In 2023, the Plasmid DNA Contract Manufacturing Market size was estimated at USD 4.72 billion. The report covers the Plasmid DNA Contract Manufacturing Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Plasmid DNA Contract Manufacturing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Plasmid DNA Contract Manufacturing Market Share

Statistics for the 2023 & 2024 Plasmid DNA Contract Manufacturing market share, created by Mordor Intelligence™ Industry Reports. Plasmid DNA Contract Manufacturing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Plasmid DNA Contract Manufacturing Industry

The plasmid DNA contract manufacturing market is moderately competitive, with the presence of both small and large players who are involved in strategic activities such as the expansion of services, partnerships, collaborations, and mergers and acquisitions. PlasmidFactory GmbH & Co. KG, Lonza, BioCina, Charles River Laboratories, and Catalent Inc. are among the notable key players in this market.